Practice of the Qualification and Recognition for Orphan Drugs in the World and its Inspiration / 罕见病研究
JOURNAL OF RARE DISEASES
; (4): 339-346, 2022.
Article
en Zh
| WPRIM
| ID: wpr-1005025
Biblioteca responsable:
WPRO
ABSTRACT
We have analyzed the current status of recognization and qualification of orphan drugs in China and abroad, looking at the aspects of the authority institutions, identification and qualification process, and the number of orphan drugs identified and available in the market. By comparing and analyzing horizontally the differences in orphan drugs identification between representative developed countries vs. some developing countries, we discuss the inadequacy of orphan drugs supervision in China. We introduce the advanced experience from the developed countries and some developing countries to provide suggestions for the identification and management of orphan drugs, hoping to speed up the process of development and market availability of orphan drugs and to maximize patient's accessibility to treatment in China.
Texto completo:
1
Base de datos:
WPRIM
Idioma:
Zh
Revista:
JOURNAL OF RARE DISEASES
Año:
2022
Tipo del documento:
Article